Glioblastoma Multiforme Brain Tumor Vaccine

Glioblastoma Multiforme Brain Tumor Vaccine Being Tested In Miami To Treat The Most Aggressive Brain Cancer

Researchers in Miami are testing what they have called a new vaccine intended to treat the most common and deadly form of brain cancer known as glioblastoma multiforme. Technically, this is not a real vaccine as they are taking cells from the patients, adding some proteins, and giving back to the system healthy cells which are intended to kill the cancer cells. With minimum side-effects from this type of bio-engineering we are able to manipulate our own immune system in order to achieve amazing results. These new clinical trials are currently being conducted by a number of different researchers in the hopes of discovering cures for the most aggressive forms of cancer such as brain tumors.

When asked whether or not this new research would have any potential benefits on curing other forms of cancer, Dr. David Samadi told

“Yes. The answer is that we are on the right path, but, of course there is a lot more research that needs to be done with this.”

This breakthrough “brain cancer vaccine” may may be used by doctors to one day treat the same deadly brain cancer that killed former senator Ted Kennedy and baseball legend Gary Carter in addition to leading to new forms of treatment for other forms of cancer.

Glioblastoma multiforme, often referred to by the acronym GBM, is the most commonly occurring aggressive malignant primary brain tumor found in the human species. GBM accounts for 52% of all brain tumor cases pertaining to functional tissue. Regardless of how prevalent GBM may seem based on these statistics, it’s certainly worth noting that GBMs only occur in 2-3 out of every 100,000 people in North America and Europe combined.